Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months

NCT01718041 is registered in ClinicalTrials.gov with Versartis Inc. as lead sponsor.

NCT NCT01718041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01718041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Lead sponsor
Versartis Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2012
Completion date
July 31, 2014
Enrollment
64 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric growth hormone deficiency